Literature DB >> 15215144

Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Julie Millet1, Marylin Torrentino-Madamet, Sandrine Alibert, Christophe Rogier, Christiane Santelli-Rouvier, Joel Mosnier, Eric Baret, Jacques Barbe, Daniel Parzy, Bruno Pradines.   

Abstract

The ability of four 9,10-dihydroethanoanthracene derivatives (BG920, BG932, BG958, and BG996), as well as verapamil and promethazine, to reverse chloroquine resistance was assessed against 24 chloroquine-resistant and 10 chloroquine-susceptible strains of Plasmodium falciparum from different countries. The 9,10-dihydroethanoanthracene derivatives clearly increase chloroquine susceptibility only in chloroquine-resistant isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215144      PMCID： PMC434228          DOI： 10.1128/AAC.48.7.2753-2756.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

1.  Failure of anti-malarial prophylaxis with mefloquine in Africa.

Authors:  P Ringwald; S Bartczak; J Le Bras; F Bricaire; S Matheron; J Bauchet; J P Coulaud
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

2.  Reversal of chloroquine resistance of 'wild' isolates of Plasmodium falciparum by desipramine.

Authors:  G Carosi; S Caligaris; G Fadat; F Castelli; A Matteelli; D Kouka-Bemba; G Roscigno
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Nov-Dec       Impact factor: 2.184

3.  Type RI resistance to halofantrine in West Africa.

Authors:  L K Basco; J Le Bras; C Gillotin; P Ringwald; E Rabenjarson; F Gimenez; O Bouchaud; R Farinotti; J P Coulaud
Journal:  Trop Med Parasitol       Date:  1991-12

4.  In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.

Authors:  A M Oduola; A Sowunmi; W K Milhous; T G Brewer; D E Kyle; L Gerena; R N Rossan; L A Salako; B G Schuster
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

5.  Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.

Authors:  Martha Kalkanidis; Nectarios Klonis; Leann Tilley; Leslie W Deady
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

6.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

Authors:  A J Bitonti; A Sjoerdsma; P P McCann; D E Kyle; A M Oduola; R N Rossan; W K Milhous; D E Davidson
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

7.  Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives.

Authors:  Sandrine Alibert; Christiane Santelli-Rouvier; Bruno Pradines; Carole Houdoin; Daniel Parzy; Janina Karolak-Wojciechowska; Jacques Barbe
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

8.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

Authors:  S K Martin; A M Oduola; W K Milhous
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

9.  Reversal of chloroquine resistance in falciparum malaria.

Authors:  J C Ryall
Journal:  Parasitol Today       Date:  1987-08

10.  In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes.

Authors:  Bruno Pradines; Sandrine Alibert; Carole Houdoin; Christiane Santelli-Rouvier; Joel Mosnier; Thierry Fusai; Christophe Rogier; Jacques Barbe; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more
  3 in total

1.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.

Authors:  Steven J Burgess; Audrey Selzer; Jane Xu Kelly; Martin J Smilkstein; Michael K Riscoe; David H Peyton
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

2.  Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Authors:  Julie Millet; Sandrine Alibert; Marylin Torrentino-Madamet; Christophe Rogier; Christiane Santelli-Rouvier; Patricia Bigot; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum.

Authors:  Simeon Andrews; Steven J Burgess; Deborah Skaalrud; Jane Xu Kelly; David H Peyton
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.